Levi & Korsinsky Notifies Shareholders of PepGen Inc.(PEPG) of a Class Action Lawsuit and an Upcoming Deadline

Core Viewpoint - A class action securities lawsuit has been filed against PepGen Inc. due to alleged securities fraud affecting investors between March 7, 2024, and March 3, 2025 [1][2] Group 1: Allegations - The lawsuit claims that PepGen's lead product candidate, PGN-EDO51, was less effective and safe than previously stated by the defendants [2] - It is alleged that the phase two CONNECT2 study was dangerous or deficient for FDA approval, leading to the likelihood of halting the study [2] - The public statements made by the defendants were materially false and misleading throughout the relevant period [2] Group 2: Legal Process - Investors who suffered losses during the specified timeframe have until August 8, 2025, to request appointment as lead plaintiff [3] - Participation in the lawsuit does not require serving as a lead plaintiff, and there are no out-of-pocket costs for class members [3] Group 3: Firm Background - Levi & Korsinsky has a strong track record, having secured hundreds of millions for shareholders and being recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [4]